JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 9, 2007; DOI: 10.1124/jpet.107.121954


0022-3565/07/3222-813-821$20.00
JPET 322:813-821, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.121954v1
322/2/813    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sykes, K. T.
Right arrow Articles by Hammond, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sykes, K. T.
Right arrow Articles by Hammond, D. L.

TOXICOLOGY

Mechanisms Responsible for the Enhanced Antinociceptive Effects of µ-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain

Kenneth T. Sykes, Stephanie R. White, Robert W. Hurley, Hirokazu Mizoguchi1, Leon F. Tseng, and Donna L. Hammond

Departments of Anesthesia (S.R.W., D.L.H.) and Pharmacology (K.T.S., D.L.H.) and the Medical Scientist Training Program (K.T.S.), The University of Iowa, Iowa City, Iowa; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin (H.M., L.F.T.); and Department of Anesthesiology and Critical Care, The Johns Hopkins University, Baltimore, Maryland (R.W.H.)

This study investigated three possible mechanisms by which the antinociceptive effects of the µ-opioid receptor (MOR) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) and the {delta}-opioid receptor (DOR) agonist [D-Ala2,Glu4]-deltorphin (deltorphin II) (DELT), microinjected into the rostral ventromedial medulla (RVM), are enhanced in rats with persistent inflammatory injury. Radioligand binding determined that neither the Bmax nor the Kd values of [3H]DAMGO differed in RVM membranes from rats that received an intraplantar injection of saline or complete Freund's adjuvant (CFA) in one hindpaw 4 h, 4 days, or 2 weeks earlier. Likewise, neither the EC50 nor the Emax value for DAMGO-induced stimulation of guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTP{gamma}S) binding differed in the RVM of saline- or CFA-treated rats at any time point. Microinjection of fixed dose combinations of DAMGO and DELT in the RVM of naive rats indicated that these agonists interact synergistically to produce antinociception when DAMGO is present in equal or greater amounts than DELT and, additively, when DELT is the predominant component. Thus, unlike the periphery or spinal cord, potentiation of MOR-mediated antinociception does not entail an increase in MOR number, affinity, or coupling. Rather, the data are concordant with our proposal that potentiation results from a synergistic interaction of exogenous MOR agonist with DOR-preferring enkephalins whose levels are increased in CFA-treated rats (J Neurosci 21:2536–2545, 2001). Virtually no specific [3H]DELT binding nor stimulation of [35S]GTP{gamma}S binding by DELT was obtained in RVM membranes from CFA- or saline-treated rats at any time point. The mechanisms responsible for the potentiation of DELT-mediated antinociception remain to be elucidated.


Received February 25, 2007; accepted May 8, 2007.

Address correspondence to: Dr. Donna L. Hammond, Department of Anesthesia, The University of Iowa, 200 Hawkins Dr. 6 JCP, Iowa City, IA 52242. E-mail: donna-hammond{at}uiowa.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. J. Hathway, S. Koch, L. Low, and M. Fitzgerald
The changing balance of brainstem\#8211;spinal cord modulation of pain processing over the first weeks of rat postnatal life
J. Physiol., June 15, 2009; 587(12): 2927 - 2935.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. Maione, K. Starowicz, L. Cristino, F. Guida, E. Palazzo, L. Luongo, F. Rossi, I. Marabese, V. de Novellis, and V. Di Marzo
Functional Interaction Between TRPV1 and {micro}-Opioid Receptors in the Descending Antinociceptive Pathway Activates Glutamate Transmission and Induces Analgesia
J Neurophysiol, May 1, 2009; 101(5): 2411 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Bie, W. Zhu, and Z. Z. Pan
Rewarding Morphine-Induced Synaptic Function of {delta}-Opioid Receptors on Central Glutamate Synapses
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 290 - 296.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.